Skip to main content

Avinger, Inc. (AVGR)

NASDAQ: AVGR · IEX Real-Time Price · USD
0.736
+0.023 (3.23%)
After-hours:Oct 22, 2021 7:58 PM EDT
0.713
-0.042 (-5.60%)
At close: Oct 22, 4:00 PM
Market Cap71.97M
Revenue (ttm)10.40M
Net Income (ttm)-20.68M
Shares Out95.35M
EPS (ttm)-0.24
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,035,438
Open0.740
Previous Close0.755
Day's Range0.704 - 0.750
52-Week Range0.214 - 2.670
Beta1.75
AnalystsBuy
Price Target2.50 (+250.9%)
Est. Earnings DateNov 9, 2021

About AVGR

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as th...

IndustryHealth Care Equipment & Supplies
IPO DateJan 30, 2015
CEOJeffrey Soinski
Employees69
Stock ExchangeNASDAQ
Ticker SymbolAVGR
Full Company Profile

Financial Performance

In 2020, Avinger's revenue was $8.76 million, a decrease of -4.05% compared to the previous year's $9.13 million. Losses were -$19.01 million, -2.28% less than in 2019.

Financial Statements

Analyst Forecast

According to 2 analysts, the average rating for Avinger stock is "Buy." The 12-month stock price forecast is 2.50, which is an increase of 250.88% from the latest price.

Price Target
$2.50
(250.88% upside)
Analyst Consensus: Buy

News

Ground-Breaking Clinical Data from INSIGHT Trial Presented at VIVA

Study Outcomes Demonstrate Safety and Efficacy of Pantheris for Treatment of In-Stent Restenosis REDWOOD CITY, CA / ACCESSWIRE / October 7, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical...

2 weeks ago - Accesswire

Avinger To Present at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15

REDWOOD CITY, CA / ACCESSWIRE / September 8, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system ...

1 month ago - Accesswire

Avinger OCT-Guided Technologies Featured at AMP 2021

REDWOOD CITY, CA / ACCESSWIRE / August 16, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system fo...

2 months ago - Accesswire

Avinger: Q2 Earnings Insights

Shares of Avinger (NASDAQ:AVGR) rose in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 77.78% year over year to ($0.04), which were in line with th...

2 months ago - Benzinga

Avinger Reports Second Quarter 2021 Financial Results

Pantheris Sales and Tigereye™ Expansion Drive 91% Year-Over-Year Revenue Growth REDWOOD CITY, CA / ACCESSWIRE / August 10, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company m...

2 months ago - Accesswire

Earnings Outlook For Avinger

Avinger (NASDAQ:AVGR) releases its next round of earnings this Tuesday, August 10. Here is Benzinga's essential guide to Avinger's Q2 earnings report.

2 months ago - Benzinga

Avinger Announces 510(k) Filing for New Lightbox 3 Imaging Console

Smaller Footprint, Improved User Experience and Lower Cost to Drive Adoption REDWOOD CITY, CA / ACCESSWIRE / August 9, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marke...

2 months ago - Accesswire

Avinger to Announce Second Quarter 2021 Results on August 10, 2021

REDWOOD CITY, CA / ACCESSWIRE / July 27, 2021 / Avinger, Inc. (Nasdaq:AVGR), commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for di...

2 months ago - Accesswire

Avinger Files US Application For New Pantheris In-Stent Restenosis Indication

Avinger Inc (NASDAQ: AVGR) has submitted a 510(k) application to the FDA for a new Pantheris clinical indication for the treatment of in-stent restenosis (ISR) in the lower extremity arteries. To submis...

3 months ago - Benzinga

Avinger Announces 510(k) Filing for New Pantheris In-Stent Restenosis Indication

REDWOOD CITY, CA / ACCESSWIRE / July 6, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for d...

3 months ago - Accesswire

5 Red-Hot Stocks Under $10 With Big Upside Potential

While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.

Other symbols:CXMOGOSCOREGLX
3 months ago - 24/7 Wall Street

Hot Penny Stocks to Buy to Avoid Inflation? 7 For Your July Watchlist

Which penny stocks are investors watching with inflation on the rise? Here's 7 for your list The post Hot Penny Stocks to Buy to Avoid Inflation?

3 months ago - PennyStocks

Avinger Announces Key Opinion Leader Presentations at Vascular Conferences in Germany

REDWOOD CITY, CA / ACCESSWIRE / June 28, 2021 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for ...

3 months ago - Accesswire

Avinger Announces Presentations by Key Opinion Leaders at New Cardiovascular Horizons Annual Conference

REDWOOD CITY, CA / ACCESSWIRE / June 7, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for d...

4 months ago - Accesswire

Avinger Announces Issuance and Allowance of Seven U.S. Patents

REDWOOD CITY, CA / ACCESSWIRE / May 25, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for d...

4 months ago - Accesswire

Avinger To Present at the Oppenheimer MedTech, Tools & Diagnostics Summit May 26

REDWOOD CITY, CA / ACCESSWIRE / May 17, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for d...

5 months ago - Accesswire

Avinger Reports First Quarter 2021 Financial Results

13% Year-over-Year Revenue Growth Driven by Tigereye™ Commercial Launch and Pantheris SV Sales Growth REDWOOD CITY, CA / ACCESSWIRE / May 6, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medica...

5 months ago - Accesswire

3 Hot Penny Stocks To Buy With Analysts Expecting Up To 383%

Penny stocks to buy according to top Wall Street analysts The post 3 Hot Penny Stocks To Buy With Analysts Expecting Up To 383% appeared first on Penny Stocks to Buy, Picks, News and Information | Penny...

Other symbols:CASIMARK
5 months ago - PennyStocks

Avinger to Announce First Quarter 2021 Results on May 6, 2021

REDWOOD CITY, CA / ACCESSWIRE / April 26, 2021 / Avinger, Inc. (NASDAQ:AVGR), commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for d...

5 months ago - Accesswire

Hot Penny Stocks To Watch In April 2021 If Biotech Is A Focus

List Of Penny Stocks To Watch Right Now The post Hot Penny Stocks To Watch In April 2021 If Biotech Is A Focus appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Other symbols:GTBPSENS
6 months ago - PennyStocks

New Publications Highlight Clinical Benefits of Avinger PAD Therapies

REDWOOD CITY, CA / ACCESSWIRE / April 21, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...

6 months ago - Accesswire

Avinger Achieves Commercial Milestone with More Than 100 Accounts Using Pantheris SV

REDWOOD CITY, CA / ACCESSWIRE / April 15, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...

6 months ago - Accesswire

Avinger Provides Update on Tigereye(TM) Commercial Launch

REDWOOD CITY, CA / ACCESSWIRE / April 8, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for ...

6 months ago - Accesswire

Target Top-Line Growth and Compelling Patient Outcomes with Avinger

It's been reported that AVGR stock is popular among Robinhood traders. That's fine, but it's more important to see the company's potential.

6 months ago - InvestorPlace

Avinger: Q4 Earnings Insights

Avinger (NASDAQ:AVGR) reported Q4 results on Thursday afternoon. Quarterly Results Earnings per share were up 87.93% over the past year to ($0.07), which missed the estimate of ($0.06).

7 months ago - Benzinga